Role Of Phospholipid Transfer Proteins (Pltp) On Endotoxemia Caused By Buccal Inflammation (TOXIB)

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Patients With Periodontal Disease

Treatments

Other: Sampling of blood

Study type

Interventional

Funder types

Other

Identifiers

NCT01950962

Lafon PHRC IR 2010

Details and patient eligibility

About

This is a transversal double-centre study. Patients will be recruited from outpatient consultations. They will have buccal inflammation caused by periodontal disease (frequent oral infections, mostly with GRAM (-) bacteria). Three groups of 80 patients, corresponding to slight, moderate and severe periodontal disease, will be formed according to the results of radiological and clinical examinations.

Enrollment

242 patients

Sex

All

Ages

35 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Pre-Inclusion criteria:

Persons aged from 35 to 80 years old
Persons who have provided written informed consent
Patients with periodontal disease whatever the severity with at least one molar or one premolar on the dental arch
Possibility to examine the oral cavity (patient able to open mouth)
Possibility to do an orthopantomogram (sitting position required and patient able to clench jaws)
Patient able to understand French
Patient who accepts to provide fasting blood sample within the five days following the initial consultation

DEFINITIVE INCLUSION CRITERIA

Patient present for the fasting blood sample within five days following the initial consultation Patients will be matched for sex and, as much as possible, for age in the three groups and for the severity of the periodontal disease

Exclusion criteria

Persons not covered by the national health insurance agency
Patients with a high risk of infectious endocarditis who require prophylaxis for any medical act involving blood
Patients who have taken at least once during the 8 days preceding the definitive inclusion an anti-inflammatory dose of NSAIDS and/or a salicylate (blood sample)
Patients who have had long-term treatment (>6 months) with corticoids at a dose of at least 15 mg per day
Patients on antibiotics less than 15 days before the blood sample
Patients with oral inflammation requiring treatment with antibiotics or anti-inflammatory drugs during the pre-inclusion
Scaling during the 24 hours before the blood sample
History of oral cancer or cancer of the pharynx
Active cancer (patient undergoing treatment or diagnosis within the previous 5 years)
Iatrogenic, spontaneous or therapeutic immunodepression (patient on immunosuppressants or antiretrovirals),
Systemic or organ specific inflammatory syndrome not related to the periodontal disease
- proven bacterial, viral or fungal Infection either developing or being treated (urinary, prostate infection)
- Inflammatory cancer (solid tumour, malignant hemopathy)
Pregnancy
Impossibility to cooperate due to a psychiatric disease, dementia
Patients unable to understand the protocol